ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,079Medicare Part D Prescriptions Filled, Including Refills

Rank: 77 out of 6645

$985K Total Retail Price of All Prescriptions

Rank: 334 out of 6645

793 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 793 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 793 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 17,177 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 1,627 1,068 1 1
ENALAPRIL MALEATE 1,316 920 10 2 75
AMLODIPINE BESYLATE 1,081 793 3 2
OMEPRAZOLE 984 644 4 6
LEVOTHYROXINE SODIUM 926 619 5 4
METFORMIN HCL 761 476 6 7
HYDRALAZINE HCL 757 625 7 77
CLONIDINE HCL 641 384 8 56
FUROSEMIDE 618 468 9 11
HYDROCODONE-ACETAMINOPHEN 501 323 S3 10 5
METOPROLOL TARTRATE 475 343 11 13
WARFARIN SODIUM 469 396 12 16
GLIMEPIRIDE 381 255 13 47
LISINOPRIL 375 269 14 3
TRAMADOL HCL 356 237 15 30
SERTRALINE HCL 333 243 16 43
POTASSIUM CHLORIDE 321 194 17 28
HYDROCHLOROTHIAZIDE 305 209 18 9
ATENOLOL 292 184 19 8
ATORVASTATIN CALCIUM 271 220 20 10
LOSARTAN POTASSIUM 265 199 21 12
ALLOPURINOL 259 210 22 31
ISOSORBIDE MONONITRATE ER 241 238 23 66
ADVAIR DISKUS 222 147 24 45
NIFEDIPINE ER 210 172 25 82
ACTOS 209 154 26 71
INSULIN SYRINGE 203 138 27 61
PAROXETINE HCL 198 130 28 72
NAMENDA 190 190 29 41
FLUOXETINE HCL 177 90 30 63
METOPROLOL SUCCINATE 171 151 31 24
GABAPENTIN 167 89 32 18
LANTUS 164 115 33 50
HUMULIN 70-30 163 130 34 328
JANUVIA 157 70 35 38
DIOVAN 157 135 35 19
ALENDRONATE SODIUM 155 123 37 14
PROAIR HFA 146 62 38 32
IBUPROFEN 139 60 39 42
NIFEDICAL XL 136 104 40 295
POLYETHYLENE GLYCOL 3350 136 99 40 121
RANITIDINE HCL 129 108 42 51
PHENYTOIN SODIUM EXTENDED 124 68 43 172
LOVASTATIN 124 111 43 15
GEMFIBROZIL 123 83 45 96
BACLOFEN 121 83 46 100
DIGOXIN 120 120 47 59
TAMSULOSIN HCL 118 74 48 22
HYDROXYZINE HCL 116 61 R 49 161
ZOLPIDEM TARTRATE 114 55 50 17
DOXAZOSIN MESYLATE 113 99 51 81
QUETIAPINE FUMARATE 109 85 52 101
DONEPEZIL HCL 102 82 53 27
PRAZOSIN HCL 97 94 54 340
TRIAMCINOLONE ACETONIDE 96 61 55 55
CARVEDILOL 95 72 56 25
CITALOPRAM HBR 90 44 57 35
AMIODARONE HCL 89 77 58 160
AMITRIPTYLINE HCL 88 37 R 59 117
LIPITOR 88 60 59 69
FENOFIBRATE 85 41 61 74
PANTOPRAZOLE SODIUM 80 74 62 29
PREDNISONE 80 76 62 57
CLOPIDOGREL 79 59 64 36
PLAVIX 78 66 65 49
GLYBURIDE 78 45 R 65 58
BENAZEPRIL HCL 78 60 65 21
ZETIA 76 41 68 87
MIRTAZAPINE 76 64 68 70
SPIRIVA 75 69 70 65
THEOPHYLLINE ANHYDROUS 74 38 71 253
PIOGLITAZONE HCL 73 55 R 72 184
CARBIDOPA-LEVODOPA 71 71 73 116
CYCLOBENZAPRINE HCL 68 17 R 74 157
RAMIPRIL 67 50 75 118
PREMARIN 67 53 R 75 169
SPIRONOLACTONE 65 51 77 85
LANTUS SOLOSTAR 65 43 77 139
TRIAMTERENE-HYDROCHLOROTHIAZID 64 20 79 143
GLIPIZIDE 62 30 80 23
TRAZODONE HCL 62 25 80 60
OLANZAPINE 61 11 82 140
DIVALPROEX SODIUM ER 60 40 83 273
FLUTICASONE PROPIONATE 60 40 83 26
TRIAMTERENE-HCTZ 60 39 83 52
DILTIAZEM 24HR ER 58 46 86 187
PEN NEEDLE 57 47 87 159
GLYBURIDE-METFORMIN HCL 56 44 R 88 95
DILTIAZEM 24HR CD 52 38 89 176
QUINAPRIL HCL 51 39 90 270
MECLIZINE HCL 51 39 90 122
NYSTATIN-TRIAMCINOLONE 50 35 92 346
NOVOLIN 70-30 50 29 92 309
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.